Patents by Inventor Uro{hacek over (s)} Jamnikar

Uro{hacek over (s)} Jamnikar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Predicting productivity in early cell line development
    Patent number: 10913985
    Abstract: The present invention relates in general to the field of recombinant protein expression. In particular, the present invention relates to a method for selecting a suitable candidate cell clone for recombinant protein expression and to a host cell for recombinant protein expression, the host cell exhibiting artificially modified gene expression of at least one gene selected from the group consisting of: Fkbp10, ZdhhC6, Myrip, Actc1, AC124993.19, Runx2, AC158560.4, PlekhB1, Rps6KA2, Sept1, Sprr2k, and Flt1.
    Type: Grant
    Filed: November 12, 2015
    Date of Patent: February 9, 2021
    Assignee: Lek Pharmaceuticals d.d.
    Inventors: Uro{hacek over (s)} Jamnikar, Marjanca Blas, Kristina Gruden
  • Predicting genetically stable recombinant protein production in early cell line development
    Patent number: 10913984
    Abstract: The present invention relates in general to the field of recombinant protein expression. In particular, the present invention relates to a method for selecting a suitable candidate cell clone for recombinant protein expression and to a host cell for recombinant protein expression, the host cell exhibiting artificially modified gene expression of at least one gene selected from the group consisting of: Hist1h2bc, Egrl, BX842664.2/Hist 1h3c, Dhfr, Fgfr2, AC115880.11, Mmp10, Vsnll (optional), CU459186.17, El 30203 B14Rik, Cspg4, C1qtnf1, Foxp2, and Ptpre.
    Type: Grant
    Filed: November 12, 2015
    Date of Patent: February 9, 2021
    Assignee: Lek Pharmaceuticals d.d.
    Inventors: Uro{hacek over (s)} Jamnikar, Kristina Gruden